- Home
- HQI vs CMPX Comparison
HQI vs CMPX Comparison
Compare HQI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- CMPX
- Stock Information
- Founded
- HQI 2002
- CMPX 2014
- Country
- HQI United States
- CMPX United States
- Employees
- HQI N/A
- CMPX N/A
- Industry
- HQI Professional Services
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- HQI Consumer Discretionary
- CMPX Health Care
- Exchange
- HQI Nasdaq
- CMPX Nasdaq
- Market Cap
- HQI 172.8M
- CMPX 217.4M
- IPO Year
- HQI N/A
- CMPX N/A
- Fundamental
- Price
- HQI $13.61
- CMPX $1.50
- Analyst Decision
- HQI Strong Buy
- CMPX Strong Buy
- Analyst Count
- HQI 2
- CMPX 2
- Target Price
- HQI $18.00
- CMPX $9.00
- AVG Volume (30 Days)
- HQI 18.5K
- CMPX 381.1K
- Earning Date
- HQI 08-08-2024
- CMPX 11-07-2024
- Dividend Yield
- HQI 1.78%
- CMPX N/A
- EPS Growth
- HQI N/A
- CMPX N/A
- EPS
- HQI 0.37
- CMPX N/A
- Revenue
- HQI $36,133,000.00
- CMPX $850,000.00
- Revenue This Year
- HQI N/A
- CMPX N/A
- Revenue Next Year
- HQI $7.62
- CMPX $950.68
- P/E Ratio
- HQI $36.27
- CMPX N/A
- Revenue Growth
- HQI 3.96
- CMPX N/A
- 52 Week Low
- HQI $11.39
- CMPX $0.77
- 52 Week High
- HQI $17.45
- CMPX $2.34
- Technical
- Relative Strength Index (RSI)
- HQI 50.11
- CMPX 60.19
- Support Level
- HQI $13.92
- CMPX $1.42
- Resistance Level
- HQI $14.73
- CMPX $1.65
- Average True Range (ATR)
- HQI 0.57
- CMPX 0.13
- MACD
- HQI -0.00
- CMPX 0.02
- Stochastic Oscillator
- HQI 44.00
- CMPX 51.95
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.